Welcome to use AbleSci to get your papers. Our English Version is under development. You can temporarily use Google to translate AbleSci. Quite easy! Thank you!

发布文献求助

漆漆漆漆漆

Lv1

100 积分 2024-06-08 加入

最近求助
最近应助
互助留言

Targeting GSDME-mediated macrophage polarization for enhanced antitumor immunity in hepatocellular carcinoma 4天前 已完结
An update on Merkel cell carcinoma 5天前 已完结
Immune Checkpoint Inhibitors in Endometrial Cancer: A Cinderella Story 7天前 已关闭
Defining clinically useful biomarkers of immune checkpoint inhibitors in solid tumours 7天前 已完结
Radiotherapy, immunity, and immune checkpoint inhibitors 8天前 已完结
HPV E6/E7: insights into their regulatory role and mechanism in signaling pathways in HPV-associated tumor 10天前 已完结
Phase 2 Study of Nivolumab in Epstein-Barr Virus (EBV)-Positive Lymphoproliferative Disorders and EBV-Positive Non-Hodgkin Lymphomas 11天前 已关闭
Phase 2 Study of Nivolumab in Epstein-Barr Virus (EBV)-Positive Lymphoproliferative Disorders and EBV-Positive Non-Hodgkin Lymphomas 11天前 已关闭
Epigenetic agents plus anti-PD-1 reshapes tumor microenvironment and restores antitumor efficacy in Hodgkin lymphoma 11天前 已完结
Epigenetic agents plus anti-PD-1 reshapes tumor microenvironment and restores antitumor efficacy in Hodgkin lymphoma 11天前 已关闭

没有进行任何应助

感谢 4天前
感谢 2个月前
速度真快，帮大忙了，么么哒 5个月前
速度真快 5个月前
感谢 7个月前

最近帖子
最近评论

没有发布任何帖子

没有发布任何评论

Copyright © 2020-2025 AbleSci.COM, 科研通, All Right Reserved

科研通是非营利科研互助平台，不忘初心，为科研助力

本站互助的所有文件仅供个人学习研究用，禁止任何人把求助的所得文献进行盈利或传播

皖ICP备2024041134号-1

皖公网安备34019202002308

科研通【文献互助QQ群】：如果您有特殊求助，或发布求助超过24小时未得到应助，可加群求助，群号：941272744【点击一键加群】

科研通【志愿服务QQ群】：如果您热爱文献互助，有热心愿意为更多人服务，请加入小伙伴群，点击申请加入

关注微信服务号

科研通